LRRK2 mutations in Basque patients with Parkinson's disease

摘要

In the article by Healy and colleagues, on behalf of the International LRRK2 Consortium,1 according to table 1, no cases of LRRK2 Gly2019Ser mutations were found in controls or in patients with sporadic or hereditary Parkinson's disease from the Basque country (Spain). We have previously reported2 21 carriers of Argl441Gly mutations and eight carriers of Gly2019Ser mutations among 108 individuals who were tested.